Pulmonary Hypertension in SSC: Differences Between Men and Women

Did you know that although women have a greater risk of systemic sclerosis (SSc), they may actually experience a lesser degree of symptoms?

But what difference does it make and how does this impact scleroderma patients? 

Researchers believe that the differences between male and female patients could dictate different treatment options.

In terms of outcomes of the disease, for example, after a period of at least two years after initial assessment, the ratio of women:men affected with SSc was 6:1 with the male gender more predictive of new onset pulmonary hypertension.

Read more about the gender gap in SSc, and how the disease affects men and women differently.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.